Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV003252168 | SCV003942445 | uncertain significance | Inborn genetic diseases | 2023-03-17 | criteria provided, single submitter | clinical testing | The c.265G>T (p.V89F) alteration is located in exon 4 (coding exon 2) of the RHBDF2 gene. This alteration results from a G to T substitution at nucleotide position 265, causing the valine (V) at amino acid position 89 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Baylor Genetics | RCV003459817 | SCV004206778 | uncertain significance | Palmoplantar keratoderma-esophageal carcinoma syndrome | 2024-01-25 | criteria provided, single submitter | clinical testing |